Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 798093, 10 pages
http://dx.doi.org/10.1155/2014/798093
Review Article

The Antihyperglycemic Effects of Rhizoma Coptidis and Mechanism of Actions: A Review of Systematic Reviews and Pharmacological Research

Tianjin Institute for Clinical Evaluation of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, No. 88 Yuquan Road, Nankai District, Tianjin 300193, China

Received 10 January 2014; Revised 10 March 2014; Accepted 18 March 2014; Published 10 April 2014

Academic Editor: Mila Emerald

Copyright © 2014 Hui Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Diabetes Programme: Diabetes Action Online,” http://www.who.int/diabetes/action_online/basics/en/index.html.
  2. D. G. Gardner and D. Shoback, Greenspan's Basic and Clinical Endocrinology, chapter 17, Mc Graw-Hill Medical, New York, NY, USA, 9th edition, 2011.
  3. V. Kumar, N. Fausto, A. K. Abbas, R. S. Cotran, and S. L. Robbins, Robbins and Cotran Pathologic Basis of Disease, Saunders, Philadelphia, Pa, USA, 7th edition, 2005.
  4. World Health Organization, “Diabetes fact sheets,” http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
  5. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China, vol. 1, Chinese Medical Science and Technology Press, Beijing, China, 2010.
  6. J. L. Liu, X. L. Meng, and Y. S. Liu, “Discussion on the ancient use of coptis chinensis for treating diabetes,” Sichuan Journal of Traditional Chinese Medicine, vol. 28, no. 4, pp. 41–43, 2010. View at Google Scholar
  7. Editorial Board of Chinese Materia Medica organized by the State Administration of Traditional Chinese Medicine, Chinese Materia Medica, Shanghai Science and Technology Publishing House, Shanghai, China, 1996.
  8. Y. Z. Fang, Practical Chinese Internal Medicine, Shanghai Science and Technology Publishing House, Shanghai, China, 1982.
  9. S. Tang, Y. Zhang, X. Tu et al., “A literature review on the current reserch of the mechanism of berberine for lowering blood sugar in type 2 diabetes patients,” Journal of Chinese Medicine, vol. 27, no. 7, pp. 850–851, 2012. View at Google Scholar
  10. J. Lan, S. L. Yang, Y. Q. Deng et al., “Overview of research on coptis chinensis,” Chinese Herbal Medicines, vol. 32, no. 12, p. 1139, 2001. View at Google Scholar
  11. Z. Y. Tian and Z. G. Li, “A review of new progress in the research of coptis chinensis,” Lishenzhen Medicine and Materia Medica Research, vol. 15, no. 10, p. 704, 2004. View at Google Scholar
  12. Z. Yuan, Application and Thinking of Hypoglycemic Effect of Rhizoma Coptidis in Diabetes Treatment, Beijing University of Chinese Medicine, Beijing, China, 2011.
  13. H. Dong, N. Wang, L. Zhao, and F. Lu, “Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 591654, 12 pages, 2012. View at Publisher · View at Google Scholar
  14. N. Narenqimuge, T. Y. Zhao, M. He, and C. Tian, “Effectiveness and safety of berberine in the treatment of type 2 diabetes: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 12, no. 1, pp. 81–91, 2012. View at Google Scholar · View at Scopus
  15. X. H. Liu, G. S. Li, L. Huang, H. Zhu, Y. L. Liu, and C. M. Ma, “Effects of berberine on expression of hepatic peroxisome proliferator-activated receptors and its target genes in type 2 diabetic chinese hamsters,” Journal of Clinical Rehabilitative Tissue Engineering Research, vol. 15, no. 24, pp. 4409–4414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. H. Wang, W. J. Wang, X. F. Wang, and W. Chen, “Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes,” Chinese Journal of Integrative Medicine, vol. 24, no. 10, pp. 926–928, 2004. View at Google Scholar · View at Scopus
  17. Z. Q. Gao, S. H. Leng, F. E. Lu, M. J. Xie, L. J. Xu, and K. F. Wang, “Effect of berberine on fructose-induced insulin resistance and expression of tumor necrosis factor-alpha in liver of rats,” Chinese Pharmacological Bulletin, vol. 24, no. 11, pp. 1479–1482, 2008. View at Google Scholar · View at Scopus
  18. Z. Q. Gao, F. E. Lu, S. H. Leng et al., “Effects of berberine on the expression of hepatocyte nuclear factor-4α in rats with fructose-induced insulin resistance,” World Chinese Journal of Digestology, vol. 16, no. 15, pp. 1681–1684, 2008. View at Google Scholar · View at Scopus
  19. Y. Zhao, F. E. Lu, S. Wu et al., “Effect of berberine on expression of ORP150 in rats with insulin resistance induced by high fructose and fat diet,” in Endocrine and Metabolic Diseases of Integrative Medicine—Clinical and Basic, pp. 301–304, 2010. View at Google Scholar
  20. X. Kuan, F. E. Lu, P. Yi et al., “Effects of berberine on glucose metabolism in insulin-resistant HepG2 cells,” in Proceedings of the Diabetes Forum of the 5th National Conference on Integrative Medicine for Endocrinology and Metabolism Diseases, pp. 137–143, 2012.
  21. S. Wu, F. E. Lu, H. Dong et al., “Effect of berberine on the pancreatic ß cell apoptosis in rats with insulin resistance,” Chinese Journal of Integrative Medicine, vol. 31, no. 10, pp. 1383–1388, 2011. View at Google Scholar
  22. G. Chen, F. E. Lu, Z. S. Wang et al., “Correlation between the amelioration of insulin resistance and protein expression of PI-3K and GLUT4 in type 2 diabetic rats treated with berberine,” Chinese Pharmacological Bulletin, vol. 24, no. 8, pp. 1007–1010, 2008. View at Google Scholar · View at Scopus
  23. H. Lu, W. C. Ye, and X. P. Ding, “Effect of berberine on insulin resistance in rat,” Journal of Liaoning College of Traditional Chinese Medicine, vol. 4, no. 4, pp. 259–260, 2002. View at Google Scholar
  24. F. Y. Ren, G. Y. Wang, and R. J. Cui, “Effect of berberine on gene expression of adiponectin in type 2 diabetic mellitus rats,” Medical Recapitulate, vol. 15, no. 14, pp. 2210–2212, 2009. View at Google Scholar
  25. G. S. Li, X. H. Liu, L. Huang et al., “Influence of berberine on expression of hepatic X receptors and their target genes in liver of Chinese hamsters with type 2 diabetes meilitus,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 20, no. 17, pp. 2099–2103, 2011. View at Google Scholar
  26. Y. Chen, Y. Li, Y. Wang, Y. Wen, and C. Sun, “Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor γ and fatty acid transferase expressions,” Metabolism: Clinical and Experimental, vol. 58, no. 12, pp. 1694–1702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. W. J. Kong, H. Zhang, D. Q. Song et al., “Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression,” Metabolism: Clinical and Experimental, vol. 58, no. 1, pp. 109–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. J. Xing, L. Zhang, T. Liu, Y. Q. Hua, P. Y. Zheng, and G. Ji, “Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver,” European Journal of Pharmacology, vol. 668, no. 3, pp. 467–471, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Yi, F. E. Lu, L. J. Xu, G. Chen, H. Dong, and K. F. Wang, “Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ,” World Journal of Gastroenterology, vol. 14, no. 6, pp. 876–883, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. S. Wang, F. E. Lu, L. J. Xu, and H. Dong, “Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells,” Acta Pharmacologica Sinica, vol. 31, no. 5, pp. 578–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Z. Liu, S. C. K. Cheung, L. L. Lan et al., “Berberine modulates insulin signaling transduction in insulin-resistant cells,” Molecular and Cellular Endocrinology, vol. 317, no. 1-2, pp. 148–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. S. Lee, W. S. Kim, K. H. Kim et al., “Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states,” Diabetes, vol. 55, no. 8, pp. 2256–2264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. S. Li, X. H. Liu, H. Zhu et al., “Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver X receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters,” Biological and Pharmaceutical Bulletin, vol. 34, no. 5, pp. 644–654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Liu, G. Li, H. Zhu et al., “Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs,” Endocrine Journal, vol. 57, no. 10, pp. 881–893, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Q. Yan, S. H. Leng, F. E. Lu, X. H. Lu, H. Dong, and Z. Q. Gao, “Effects of berberine on expression of hepatocyte nuclear factor 4α and glucokinase activity in mouse primary hepatocytes,” China Journal of Chinese Materia Medica, vol. 33, no. 18, pp. 2105–2109, 2008. View at Google Scholar · View at Scopus
  36. Z. Q. Yan, S. H. Leng, F. E. Lu, X. H. Lu, H. Dong, and Z. Q. Gao, “Effects of berberine on expression of hepatocyte nuclear factor 6 and glucokinase activity in mouse primary hepatocytes,” World Chinese Journal of Digestology, vol. 15, no. 36, pp. 3842–3846, 2007. View at Google Scholar · View at Scopus
  37. J. Yin, R. M. HU, J. F. Tang et al., “Glucose-lowering effect of berberine in vitro,” Journal of Shanghai Second Medical University, vol. 21, no. 5, pp. 425–427, 2001. View at Google Scholar
  38. S. Shu, X. M. Liu, L. N. Song et al., “Effects of berberine on the gene expression of IRS-1/-2 and p85 in type 2 diabetes mellitus rats,” Zhejiang Journal of Traditional Chinese Medicine, vol. 44, no. 4, pp. 254–257, 2009. View at Google Scholar
  39. W. L. Duan, Y. M. Li, X. F. Yang et al., “Effects of berberine on glucose transporter IV in skeletal muscle of type 2 diabetic rats,” Chinese Journal of Integrative Medicine, vol. 19, pp. 82–83, 1999. View at Google Scholar
  40. Q. M. Chen and M. Z. Xie, “Effects of berberine on blood glucose regulation of normal mice,” Acta Pharmaceutica Sinica, vol. 22, no. 3, pp. 161–165, 1987. View at Google Scholar · View at Scopus
  41. Q. J. Lv, S. Q. Cao, and Q. H. Pu, “Effect of berberine on secretion of GLP-1 in diabetic rats,” Neijiang Science and Technology, vol. 31, no. 12, p. 64, 2010. View at Google Scholar
  42. W. G. Hua, J. M. Song, H. Liao et al., “Effect of Huang Lian Su on nerve conduction velocity and hormone level to diabetic neuropathy in rats,” Labeled Immunoassays and Clinical Medicine, vol. 8, no. 4, pp. 212–214, 2001. View at Google Scholar
  43. H. Zhang, W. J. Kong, and J. D. Jiang, “Berberine raised insulin receptor expression through protein kinase C-dependent pathway,” in Proceedings of the Chemistry of Traditional Chinese Medicine Session of the 2008 Symposium of the Chinese Assosciation of Traditional Chinese Meidicine, pp. 191–195, 2008.
  44. X. Xie, W. Y. Li, and H. Q. Huang, “Berberine reduced blood sugar in alloxan-induced diabetic mice through activation of Akt signaling pathway,” in Proceedings of the 11th Central and South China Symposium of Experimental Animal Science and Technology, pp. 540–555, 2011.
  45. T. Z. Rong, F. E. Lu, G. Chen, L. J. Xu, K. F. Wang, and X. Zou, “Effect of berberine on glucokinase and its related glucose metabolism in rats with insulin-secretion deficiency,” Chinese Traditional and Herbal Drugs, vol. 38, no. 5, pp. 725–728, 2007. View at Google Scholar · View at Scopus
  46. C. Chen, Y. Zhang, and C. Huang, “Berberine inhibits PTP1B activity and mimics insulin action,” Biochemical and Biophysical Research Communications, vol. 397, no. 3, pp. 543–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. S. Lu, Y. L. Yu, H. J. Zhu et al., “Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats,” Journal of Endocrinology, vol. 200, no. 2, pp. 159–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. G. V. Rayasam, V. K. Tulasi, S. Sundaram et al., “Identification of berberine as a novel agonist of fatty acid receptor GPR40,” Phytotherapy Research, vol. 24, no. 8, pp. 1260–1263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Zhang, Y. C. Xu, F. J. Guo, Y. Meng, and M. L. Li, “Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus,” Chinese Medical Journal, vol. 121, no. 21, pp. 2124–2128, 2008. View at Google Scholar · View at Scopus
  50. L. Liu, Y. Deng, S. Yu, S. Lu, L. Xie, and X. Liu, “Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats,” Pharmazie, vol. 63, no. 5, pp. 384–388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. Cheng, T. Pang, M. Gu et al., “Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK,” Biochimica et Biophysica Acta: General Subjects, vol. 1760, no. 11, pp. 1682–1689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. H. Kim, E. J. Shin, E. D. Kim, T. Bayaraa, S. C. Frost, and C. K. Hyun, “Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes,” Biological and Pharmaceutical Bulletin, vol. 30, no. 11, pp. 2120–2125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Xie, W. Li, T. Lan et al., “Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway,” Endocrine Journal, vol. 58, no. 9, pp. 761–768, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Bustanji, M. O. Taha, A. M. Yousef, and A. G. Al-Bakri, “Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 21, no. 2, pp. 163–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Liu, Y. L. Yu, J. S. Yang et al., “Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 381, no. 4, pp. 371–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Q. Li, D. Y. Zuo, X. D. Qie et al., “Berberine acutely inhibits the digestion of maltose in the intestine,” Journal of Ethnopharmacology, vol. 142, no. 2, pp. 474–480, 2012. View at Google Scholar
  57. I. M. Al-Masri, M. K. Mohammad, and M. O. Tahaa, “Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 24, no. 5, pp. 1061–1066, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Cok, C. Plaisier, M. J. Salie, D. S. Oram, J. Chenge, and L. L. Louters, “Berberine acutely activates the glucose transport activity of GLUT1,” Biochimie, vol. 93, no. 7, pp. 1187–1192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Xia, J. Yan, Y. Shen et al., “Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis,” PLoS ONE, vol. 6, no. 2, Article ID e16556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Yin, Z. Gao, D. Liu, Z. Liu, and J. Ye, “Berberine improves glucose metabolism through induction of glycolysis,” American Journal of Physiology—Endocrinology and Metabolism, vol. 294, no. 1, pp. E148–E156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Y. Pan, Z. J. Huang, G. J. Wang et al., “The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption,” Planta Medica, vol. 69, no. 7, pp. 632–636, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Wang, Z. M. Yuan, H. W. Kong et al., “Exploring the mechanism of rhizoma coptidis in treating type II diabetes mellitus based on metabolomics by gas chromatography-mass spectrometry,” Chinese Journal of Chromatography, vol. 30, no. 1, pp. 8–13, 2012. View at Google Scholar
  63. M. K. He, F. E. Lu, K. F. Wang et al., “Effect and mechanisms of berberine on hyperlipidemic and insulin resistant rat,” Chinese Journal of Hospital Pharmacy, vol. 24, no. 7, pp. 389–391, 2004. View at Google Scholar
  64. J. Y. Zhou and S. W. Zhou, “Effects of berberine the expression of PPARs/PTEFb in adipose tissue of type 2 diabetic rats,” in Proceedings of the Symposium on Medicinal Chemistry and Analysis of the Active Components of Chinese Herbal Medicine, pp. 188–199, 2008.
  65. L. B. Zhou, Y. Yang, J. F. Ta et al., “Effects of berberine on glucose metabolism in adipocyte,” Journal of Shanghai Second Medical University, vol. 22, no. 5, pp. 412–414, 2002. View at Google Scholar
  66. J. Zhou and S. Zhou, “Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 390–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Zhou, Y. Yang, X. Wang et al., “Berberine stimulates glucose transport through a mechanism distinct from insulin,” Metabolism: Clinical and Experimental, vol. 56, no. 3, pp. 405–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Y. Zhou, S. W. Zhou, K. B. Zhang et al., “Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats,” Biological and Pharmaceutical Bulletin, vol. 31, no. 6, pp. 1169–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. J. F. Dai, Research on the therapeutic effect and mechanism of Berberine in Rats with Type 2 Diabetes mellitus [M.S. thesis], Luzhou Medical College, 2009.
  70. J. Qin, Effects of berberine on NF-κB activation and its downstream inflammatory factors expression in LPS—induced rat mesangial cells [M.S. thesis], Sun Yat-sen University, 2010.
  71. X. Y. Liu, Change of vascular smooth muscle reactivity in T2DM rats and intervention of Berberine [M.S. thesis], Luzhou Medical College, 2012.
  72. Z. Y. Qin, W. H. Liu, and H. Q. Huang, “Effects of berberine on fibronectin and p38MAPK signal pathway in rat glomerular mesangial cells cultured under high glucose condition,” Chinese Pharmacological Bulletin, vol. 25, no. 9, pp. 1201–1205, 2009. View at Google Scholar · View at Scopus
  73. D. Wu, W. Wen, C. L. Qi et al., “Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin,” Phytomedicine, vol. 19, no. 8-9, pp. 712–718, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Lan, X. Shen, P. Liu et al., “Berberine ameliorates renal injury in diabetic C57BL/6 mice: involvement of suppression of SphK-S1P signaling pathway,” Archives of Biochemistry and Biophysics, vol. 502, no. 2, pp. 112–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. W. H. Liu, Z. Q. Hei, H. Nie et al., “Berberine ameliorates renal injury in streptopzotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase,” Chinese Medical Journal, vol. 121, no. 8, pp. 706–712, 2008. View at Google Scholar · View at Scopus
  76. W. Liu, P. Liu, S. Tao et al., “Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose,” Archives of Biochemistry and Biophysics, vol. 475, no. 2, pp. 128–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. J. F. P. Wojtaszewski, B. F. Hansen, B. Kiens, and E. A. Richter, “Insulin signaling in human skeletal muscle: time course and effect of exercise,” Diabetes, vol. 46, no. 11, pp. 1775–1781, 1997. View at Google Scholar · View at Scopus
  78. L. C. Song, K. Z. Chen, and J. Y. Zhu, “The effect of Coptis chinensis on lipid peroxidation and antioxidases activity in rats,” Chinese Journal of Integrative Medicine, vol. 12, no. 7, pp. 421–423, 1992. View at Google Scholar · View at Scopus
  79. L. L. Qiao, F. Huang, X. G. Yan et al., “Effects of berberine on AMPK expression in skeletal muscle of metabolic syndrome rat,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 25, no. 1, pp. 145–148, 2010. View at Google Scholar
  80. J. C. Li, X. L. Meng, X. J. Fan, X. Lai, Y. Zhang, and Y. Zeng, “Pharmacodyamic material basis of Rhizoma Coptidis on insulin resistance,” China Journal of Chinese Materia Medica, vol. 35, no. 14, pp. 1855–1858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Jiang, Insulin resistance mechanism of huanglian-renshen pair in type 2 diabetes mellitus [Ph.D. thesis], Beijing University of Traditional Chinese Medicine, 2006.
  82. M. Jiang, S. D. Wang, Y. Y. Huang et al., “An experimental study on paired medicines of coptidis and ginseng for the treatment of type 2 diabetic insulin-resistance,” New Journal of Traditional Chinese Medicine, vol. 38, no. 5, pp. 89–91, 2006. View at Google Scholar
  83. L. F. Li, S. D. Wang, and M. Jiang, “Effect of ginseng and coptis on glucosemetabolism and lipometabolism in type II diabetes mellitus in rats,” Chinese Journal of Basic Medicine in Traditional Chinese Medicine, vol. 12, no. 9, pp. 707–708, 2006. View at Google Scholar
  84. Y. G. Song, Experimental research of combination of astragalus root, siberian solomonseal rhizome and coptis root on lowering blood sugar [M.S. thesis], Shandong University of Traditional Chinese Medicine, 2002.
  85. N. N. Xu, B. C. Zhu, Z. Wang et al., “Effect of san huang compound on metabolism of glucose and lipid in type II diabetes mellitus rats,” Lishenzhen Medicine and Materia Medica Research, vol. 19, no. 11, pp. 2677–2679, 2008. View at Google Scholar
  86. J. Zhao, Comparative study on therapeutic effect and its mechanism of coptidis rhizome, rehmannia dride rhizome and their compatibility on type 2 diabetic mellitus rats [M.S. thesis], Huazhong University of Science and Technology, 2011.
  87. H. F. Li, Y. Z. Zhu, Q. Ye et al., “Experimental study of the hypoglycemic effect of Jinlian Jiangtang capsule,” Chinese Traditional Patent Medicine, vol. 30, no. 6, pp. 913–914, 2008. View at Google Scholar
  88. H. Tang, L. Zhu, and L. H. Wang, “Effect of Jinqi Jiangtang tablets on serum resistin in insulin resistance rats,” Chinese Journal of Clinical Medicine Research, vol. 192, pp. 1–2, 2008. View at Google Scholar
  89. Q. Qian, X. Liu, W. He et al., “TG accumulation inhibitory effects of Jinqi formula by AMPK signaling pathway,” Journal of Ethnopharmacology, vol. 143, no. 1, pp. 41–48, 2012. View at Publisher · View at Google Scholar